Ювенилен паркинсонизъм – Дистония-паркинсонизъм, Атаксия-паркинсонизъм, Спастична параплегия-паркинсонизъм, Паркинсонизъм при нарушение на обмяната на металите – II част

Anheim, M., Lagier-Tourenne, C., Stevanin, G., Fleury, M., Durr, A., Namer, I., Denora, P., Brice, A., Mandel, J., Koenig, M., Tranchant, C. SPG11 spastic paraplegia. A new cause of juvenile parkinsonism. J Neurol, 2009, 256, 1, 104-108.

Botsford, E., George, J., Buckley, E. Parkinson's Disease and Metal Storage Disorders: A Systematic Review. Brain Sci 2018, 31, 8, 11, 194.

Bragg, D., Sharma, N., Ozelius, L. X-Linked Dystonia-Parkinsonism: recent advances. Curr Opin Neurol, 2019, 32, 4, 604-609.

Brashear, A., Dobyns, W., de Carvalho, P., Borg, M., Frijns, C., Gollamudi, S., Green, A., Guimaraes, J., Haake, B., Klein, C., Linazasoro, G., Münchau, A., Raymond, D., Riley, D., Saunders-Pullman, R., Tijssen, M., Webb, D., Zaremba, J., Bressman, S., Ozelius, L.. The phenotypic spectrum of rapid-onset dystoniaparkinsonism (RDP) and mutations in the ATP1A3 gene. Brain, 2007, 130, Pt 3, 828-835.

Brockmann, K., Simpson, M., Faber, A., Bönnemann, C., Crosby, A., Gärtner, J. Complicated hereditary spastic paraplegia with thin corpus callosum (HSP-TCC) and childhood onset. Neuropediatrics, 2005, 36, 4, 274-278.

Camargos, S., Lees, A., Singleton, A., Cardoso, F. DYT16: the original cases. J Neurol Neurosurg Psychiatry, 2012, 83, 10, 1012-1014.

Carecchio, M., Zorzi, G., Ragona, F., Zibordi, F., Nardocci, N. ATP1A3-related disorders: An update. Eur J Paediatr Neurol, 2018, 22, 2, 257-263.

Casa-Fages, B., Fernández-Eulate, G., Gamez, J., Barahona-Hernando, R., Morís, G., García-Barcina, M., Infante, J., Zulaica, M., Fernández-Pelayo, U., Muñoz-Oreja, M., Urtasun, M., Olaskoaga, A., Zelaya, V., Jericó, I., Saez-Villaverde, R., Catalina, I., Sola, E., Martínez-Sáez, E., Pujol, A., Ruiz, M., Schlüter, A., Spinazzola, A., Muñoz-Blanco, J., Grandas, F., Holt, I., Álvarez, V., López de Munaín, A. Mitochondrial Parkinsonism due to SPG7/Paraplegin variants with secondary mtDNA depletion. Mov Disord, 2019, 34, 12, 1932-1933.

Crosiers, D., Ceulemans, B., Meeus, B., Nuytemans, K., Pals,. P, Van Broeckhoven, C., Cras, P., Theuns, J. Juvenile dystoniaparkinsonism and dementia caused by a novel ATP13A2 frameshift mutation. Parkinsonism Relat Disord,. 2011, 17, 2, 135-138.

Coarelli, G., Schule, R., van de Warrenburg, B., De Jonghe, P., Ewenczyk, C., Martinuzzi, A., Synofzik, M., Hamer, E., Baets, J., Anheim, M., Schöls, L., Deconinck, T., Masrori, P., Fontaine, B., Klockgether, T., D'Angelo, M., Monin, M., De Bleecker, J., Migeotte, I., Charles, P., Bassi, M., Klopstock, T., Mochel, F., Ollagnon-Roman, E., D'Hooghe, M., Kamm, C., Kurzwelly, D., Papin, M., Davoine, C., Banneau, G., Tezenas du Montcel, S., Seilhean, D., Brice, A., Duyckaerts, C., Stevanin, G., Durr. A. Loss of paraplegin drives spasticity rather than ataxia in a cohort of 241 patients with SPG7. Neurology, 2019, 92, 23, e2679-e2690.

Di Fonzo, A., Chien, H., Socal, M., Giraudo, S., Tassorelli, C., Iliceto, G., Fabbrini, G., Marconi, R., Fincati, E., Abbruzzese, G., Marini, P., Squitieri, F., Horstink, M., Montagna, P., Libera, A., Stocchi, F., Goldwurm, S., Ferreira, J., Meco, G., Martignoni, E., Lopiano, L., Jardim, L., Oostra, A., Barbosa, E.; Italian Parkinson Genetics Network; Bonifati V. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology,. 2007, 8, 68, 19, 1557-1562.

de Carvalho, P., Sweadner, K., Penniston, J., Zaremba, J., Liu, L., Caton, M., Linazasoro, G., Borg, M., Tijssen, M., Bressman, S., Dobyns, W., Brashear, A., Ozelius, L. Mutations in the Na+/K+ - ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron, 2004, 22, 43, 1, 169-175.

Donzuso, G., Mostile, G., Nicoletti, A., Zappia, M. Basal ganglia calcifications (Fahr's syndrome): related conditions and clinical features. Neurol Sci, 2019, 40, 11, 2251-2263.

Duat-Rodríguez, A., Prochazkova, M., Sebastian, I., Extremera, V., Legido, М, Palero, S., Ortiz Cabrera, N. ATP1A3-related disorders in the differential diagnosis of acute brainstem and cerebellar dysfunction. Eur J Paediatr Neurol, 2021, 34, 105-109.

Franco, G., Lazzeri, G., Di Fonzo, A. Parkinsonism and ataxia. J Neurol Sci, 2022, 15, 433, 120020.

Gasser, T. Genetics of Parkinson's disease. Curr Opin Neurol, 2005, 18, 4, 363-369.

Giri, A., Guven, G., Hanagasi, H., Hauser, A., Erginul-Unaltuna, N., Bilgic, B., Gurvit, H., Heutink, P., Gasser, T., Lohmann, E., Simón-Sánchez, J. PLA2G6 Mutations Related to Distinct Phenotypes: A New Case with Early-onset Parkinsonism. Tremor Other Hyperkinet Mov, 2016, 16, 6, 363.

Guella, I., Sherman, H., Appel-Cresswell, S., Rajput, A., Rajput, AH., Farrer, M. Parkinsonism in GTP cyclohydrolase 1 mutation carriers. Brain, 2015, 138, 5, e349.

Guidubaldi, A., Piano, C., Santorelli, F., Silvestri, G., Petracca, M., Tessa, A., Bentivoglio, A. Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levo dopa-responsive Parkinsonism. Mov Disord, 2011, 26, 3, 553-556.

Guadagnolo, D., Piane, M., Torrisi, M., Pizzuti, A., Petrucci, S. Genotype-Phenotype Correlations in Monogenic Parkinson Disease: A Review on Clinical and Molecular Findings. Front Neurol, 2021, 12, 648588.

Gwinn-Hardy, K., Singleton, A., O'Suilleabhain, P., Boss, M., Nicholl, D., Adam, A., Hussey, J., Critchley, P., Hardy, J., Farrer, M. Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family. Arch Neurol, 2001, 58, 2, 296-299.

Haq, I., Snively, B., Sweadner, K., Suerken, C., Cook, J., Ozelius, L., Miller, C., McCall, W., Whitlow, C., Brashear, A. Revising rapid-onset dystonia-parkinsonism: Broadening indications for ATP1A3 testing. Mov Disord, 2019, 34, 10, 1528-1536.

Hedera, P. Wilson's disease: A master of disguise. Parkinsonism Relat Disord, 2019, 59, 140-145.

Hogarth, P. Neurodegeneration with brain iron accumulation: diagnosis and management. J Mov Disord, 2015, 8, 1, 1-13.

Kawarai, T., Morigaki, R., Kaji, R., Goto, S. Clinicopathological Phenotype and Genetics of X-Linked Dystonia-Parkinsonism (XDP; DYT3; Lubag). Brain Sci, 2017, 26, 7, 7, 72.

Karkheiran, S., Shahidi, G., Walker, R., Paisán-Ruiz, C. PLA2G6-associated Dystonia-Parkinsonism: Case Report and Literature Review. Tremor Other Hyperkinet Mov, 2015, 10, 5, 317.

Levi, S., Finazzi, D. Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms. Front Pharmacol, 2014, 5, 99.

Lewthwaite, A., Lambert, T., Rolfe, E., Olgiati, S., Quadri, M., Simons, E., Morrison, K., Bonifati, V., Nicholl, D. Novel GCH1 variant in Dopa-responsive dystonia and Parkinson's disease. Parkinsonism Relat Disord, 2015, 21, 4, 394-397.

Leuzzi, V., Nardecchia, F., Pons, R., Galosi, S. Parkinsonism in children: Clinical classification and etiological spectrum. Parkinsonism Relat Disord, 2021, 82, 150-157.

Lorincz, M. Neurologic Wilson's disease. Ann N Y Acad Sci, 2010, 1184, 173-187.

Lorincz, M. Recognition and treatment of neurologic Wilson's disease. Semin Neurol, 2012, 32, 5, 538-543.

Mencacci, N., Isaias, I., Reich, M., Ganos, C., Plagnol, V., Polke, J., Bras, J., Hersheson, J., Stamelou, M., Pittman, A., Noyce, A., Mok, K., Opladen, T., Kunstmann, E., Hodecker, S., Münchau, A., Volkmann, J., Samnick, S., Sidle, K., Nanji, T., Sweeney, M., Houlden, H., Batla, A., Zecchinelli, A., Pezzoli, G., Marotta, G., Lees, A., Alegria, P., Krack, P., Cormier-Dequaire, F., Lesage, S., Brice, A., Heutink, P., Gasser, T., Lubbe, S., Morris, H., Taba, P., Koks, S., Majounie, E., Gibbs, J., Singleton, A., Hardy, J., Klebe, S., Bhatia, K., Wood, N, International Parkinson’s Disease Genomics Consortium and UCL-exomes consortium. Parkinson's disease in GTP cyclohydrolase 1 mutation carriers. Brain, 2014, 137, Pt 9, 2480-2492.

Morales-Briceño, H., Mohammad, S., Post, B., Fois, A., Dale, R., Tchan, M., Fung, V. Clinical and neuroimaging phenotypes of genetic parkinsonism from infancy to adolescence. Brain, 2020, 1, 143, 3, 751-770.

Niemann, N., Jankovic, J. Juvenile parkinsonism: Differential diagnosis, genetics, and treatment. Parkinsonism Relat Disord, 2019, 67, 74-89.

Oliveira, J., Spiteri, E., Sobrido, M., Hopfer, S., Klepper, J., Voit, T., Gilbert, J., Wszolek, Z., Calne, D., Stoessl, A., Hutton, M., Manyam, B., Boller, F., Baquero, M., Geschwind, D. Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease). Neurology, 2004, 63, 2165-2167.

Park, H., Kim, H., Jeon, B. Parkinsonism in spinocerebellar ataxia. Biomed Res Int, 2015, 2015, 125273.

Pedroso, J., Vale, T., Bueno, F., Marussi, V., Amaral, L., França, M. SPG7 with parkinsonism responsive to levodopa and dopaminergic deficit. Parkinsonism Relat Disord, 2018, 47, 88-90.

Potulska-Chromik, A., Hoffman-Zacharska, D., Łukawska, M., Kostera-Pruszczyk, A. Dopa-responsive dystonia or early-onset Parkinson disease - Genotype-phenotype correlation. Neurol Neurochir Pol, 2017, 51, 1, 1-6.

Pulai, S., Biswas, A., Roy, A., Guin, D., Pandit, A., Gangopadhyay, G., Ghorai, P., Sarkhel, S., Senapati, A.. Clinical features, MRI brain, and MRS abnormalities of drug-naïve neurologic Wilson's disease. Neurol India, 2014, 62, 2, 153-158.

Quadri, M., Olgiati, S., Sensi, M., Gualandi, F., Groppo, E., Rispoli, V., Graafland, J., Breedveld, G., Fabbrini, G., Berardelli, A., Bonifati, V. PRKRA Mutation Causing Early-Onset Generalized Dystonia-Parkinsonism (DYT16) in an Italian Family. Mov Disord, 2016, 31, 5, 765-767.

Quintаns, B., Oliveira, J., Sobrido, M.. Primary familial brain calcifications. Handb Clin Neurol, 2018, 147, 307-317.

Rengmark, A., Pihlstrøm, L., Linder, J., Forsgren, L., Toft, M. Low frequency of GCH1 and TH mutations in Parkinson's disease. Parkinsonism Relat Disord, 2016, 29, 109-111.

Riboldi, G., Frattini, E., Monfrini, E., Frucht, S., Di Fonzo, A. A Practical Approach to Early-Onset Parkinsonism. J Parkinsons Dis, 2022, 12, 1, 1-26.

Rudakou, U., Bencheikh, B., Ruskey, J., Krohn, L., Laurent, S., Spiegelman, D., Liong, C., Fahn, S., Waters, C., Monchi, O., Fon, E., Dauvilliers, Y., Alcalay, R., Dupré, N., Gan-Or, Z. Common and rare GCH1 variants are associated with Parkinson's disease. Neurobiol Aging, 2019, 73, 231.e1-231.e6.

Salles, P., Terán-Jimenez, M., Vidal-Santoro, A., Chaná-Cuevas, P., Kauffman, M., Espay, A.. Recognizing Atypical Dopa-Responsive Dystonia and Its Mimics. Neurol Clin Pract, 2021, 11, 6, e876-e884.

Salles, P., Mata, I., Brünger, T., Lal, D., Fernandez, H.. ATP1A3- Related Disorders: An Ever-Expanding Clinical Spectrum. Front Neurol, 2021, 1, 12, 637890.

Synofzik, M. Parkinsonism in neurodegenerative diseases predominantly presenting with ataxia. Int Rev Neurobio,. 2019, 149, 277-298.

Thomas, M., Hayflick, S., Jankovic, J. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration. Mov Disord, 2004, 19, 1, 36-42.

Tonekaboni, S., Mollamohammadi, M. Neurodegeneration with Brain Iron Accumulation: An Overview. Iran J Child Neurol, 2014, 8, 4, 1-8.

Tranchant, C., Koob, M., Anheim, M. Parkinsonian-Pyramidal syndromes: A systematic review. Parkinsonism Relat Disord, 2017, 39, 4-16.

Vezyroglou, A., Akilapa, R., Barwick, K., Koene, S., Brownstein, C., Holder-Espinasse, M., Fry, A., Németh, A., Tofaris, G., Hay, E., Hughes, I., Mansour, S., Mordekar, S., Splitt, M., Turnpenny, P., Demetriou, D., Koopmann, T., Ruivenkamp, C., Agrawal, P., Carr, L., Clowes, V., Ghali, N., Holder, S., Radley, J., Male, A., Sisodiya, S., Kurian, M., Cross, J., Balasubramanian, M. The Phenotypic Continuum of ATP1A3-Related Disorders. Neurology, 2022, 99, 14, 1511-1526.

Viveiros, A., Beliveau, V., Panzer, M., Schaefer, B., Glodny, B., Henninger, B., Tilg, H., Zoller, H., Scherfler, C. Neurodegeneration in Hepatic and Neurologic Wilson's Disease. Hepatology, 2021, 74, 2, 1117-1120.

Ware, T., Srinivasan, J., Gonzalez, L., Hardikar, W., Scheinberg, A., Baker, L., Prakash, C., Ryan, M. Juvenile Parkinsonism. J Paediatr Child Health, 2013, 49, 5, 409-411.

Wijemanne, S., Jankovic, J. Dopa-responsive dystonia--clinical and genetic heterogeneity. Nat Rev Neurol, 2015, 11, 7, 414-424.

Xu, Q., Li, K., Sun, Q., Ding, D., Zhao, Y., Yang, N., Luo, Y., Liu, Z., Zhang, Y., Wang, C., Xia, K., Yan, X., Jiang, H., Shen, L., Tang, B., Guo, J.. Rare GCH1 heterozygous variants contributing to Parkinson's disease. Brain, 2017, 140, 7, 41.

Yan, Y., Zhang, B., Shen, T., Si, X., Guo, Z., Tian, J., Xu, C., Zhang, B.. Study of GCH1 and TH genes in Chinese patients with Parkinson's disease. Neurobiol Aging, 2018, 68, 159.e3-159.e6.

Yoshino, H., Nishioka, K., Li, Y., Oji, Y., Oyama, G., Hatano, T., Machida, Y., Shimo, Y., Hayashida, A., Ikeda, A., Mogushi, K., Shibagaki, Y., Hosaka, A., Iwanaga, H., Fujitake, J., Ohi, T., Miyazaki, D., Sekijima, Y., Oki, M., Kusaka, H., Fujimoto, K., Ugawa, Y., Funayama, M., Hattori, N. GCH1 mutations in doparesponsive dystonia and Parkinson's disease. J Neurol, 2018, 265, 8, 1860-1870.

Zech, M., Castrop, F., Schormair, B., Jochim, A., Wieland, T., Gross, N., Lichtner, P., Peters, A,, Gieger, C., Meitinger, T., Strom, T., Oexle, K., Haslinger, B., Winkelmann, J. DYT16 revisited: exome sequencing identifies PRKRA mutations in a European dystonia family. Mov Disord, 2014, 29, 12, 1504-1510.